Skip to main content
Livermore
Livermore
ZHEN

Sigma Planning Corp

SEC CIK
0001449126
Latest filing
Aug 7, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Sigma Planning Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
60,612
Value
$1.09M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SRPT by Sigma Planning Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202660,612$1.09M<0.1%−448−0.7%ReducedHolders
Q1 202661,060$1.33M<0.1%+2,515+4.3%AddedHolders
Q4 202558,545$1.26M<0.1%+36,299+163.2%AddedHolders
Q3 202522,246$428.7K<0.1%−1,985−8.2%ReducedHolders
Q2 202524,231$414.4K<0.1%+15,012+162.8%AddedHolders
Q1 20259,219$588.4K<0.1%−1,321−12.5%ReducedHolders
Q4 202410,540$1.28M<0.1%−309−2.8%ReducedHolders
Q3 202410,849$1.35M<0.1%−356−3.2%ReducedHolders
Q2 202411,205$1.77M0.1%−1,170−9.5%ReducedHolders
Q1 202412,375$1.60M0.1%+7,162+137.4%AddedHolders
Q4 20235,213$502.7K<0.1%−7,192−58.0%ReducedHolders
Q3 202312,405$1.50M0.1%+300+2.5%AddedHolders
Q2 202312,105$1.39M<0.1%−109−0.9%ReducedHolders
Q1 202312,214$1.68M0.1%−590−4.6%ReducedHolders
Q4 202212,804$1.66M0.1%−82−0.6%ReducedHolders
Q3 202212,886$1.42M0.1%−522−3.9%ReducedHolders
Q2 202213,408$1.00M<0.1%−242−1.8%ReducedHolders
Q1 202213,650$1.07M<0.1%−130−0.9%ReducedHolders
Q4 202113,780$1.24M<0.1%+220+1.6%AddedHolders
Q3 202113,560$1.25M<0.1%+40+0.3%AddedHolders
Q2 202113,520$1.05M<0.1%−1,028−7.1%ReducedHolders
Q1 202114,548$1.08M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.